Abbott Laboratories (ABT) Market Capitalization (2009 - 2026)

Abbott Laboratories has disclosed Market Capitalization across 18 years of filings, most recently posting $157.0 billion for Q2 2026.

• In Q2 2026, Market Capitalization fell 33.67% year-over-year to $157.0 billion; the TTM figure through Jun 2026 stood at $157.0 billion (down 33.67% YoY), while the FY2025 annual figure was $217.7 billion, up 10.98% from the prior year.
• Market Capitalization came in at $157.0 billion for Q2 2026 at Abbott Laboratories, down from $178.8 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $236.7 billion in Q2 2025 to a low of $157.0 billion in Q2 2026.
• Average Market Capitalization over 5 years is $194.9 billion, with a median of $190.9 billion recorded in 2023.
• Year-over-year, Market Capitalization soared 30.93% in 2025 and slumped 33.67% in 2026.
• Over 5 years, Market Capitalization stood at $190.8 billion in 2022, then increased by 0.1% to $191.0 billion in 2023, then advanced by 2.71% to $196.2 billion in 2024, then increased by 10.98% to $217.7 billion in 2025, then fell by 27.88% to $157.0 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $157.0 billion in Q2 2026, $178.8 billion in Q1 2026, and $217.7 billion in Q4 2025.